Brown Brothers Harriman & CO Incyte Corp Transaction History

Brown Brothers Harriman & CO

$13.6 Billion
Q1 2025

A detailed history of Brown Brothers Harriman & CO transactions in Incyte Corp stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 107 shares of INCY stock, worth $6,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107

Previous 67 59.7%

Holding current value

$6,931

Previous $4,000 50.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$60.0 - $75.26 $2,400 - $3,010	40 Added 59.7%	107 $6,000
Q4 2024 Feb 12, 2025	BUY	$65.08 - $83.38 $4,360 - $5,586	67 New	67 $4,000
Q2 2023 Aug 07, 2023	SELL	$60.95 - $75.51 $121 - $151	-2 Reduced 18.18%	9 $0
Q1 2023 May 11, 2023	SELL	$70.23 - $86.01 $4,003 - $4,902	-57 Reduced 83.82%	11 $0
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $595 - $745	9 Added 15.25%	68 $5,000
Q2 2022 Aug 11, 2022	BUY	$66.18 - $83.18 $3,904 - $4,907	59 New	59 $4,000
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $2,076 - $2,275	-26 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$76.02 - $100.5 $1,976 - $2,613	26 New	26 $2,000
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $1,453 - $1,758	-18 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $1,335 - $1,960	18 New	18 $2,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $2,211 - $3,008	-35 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $1,893 - $2,249	26 Added 288.89%	35 $3,000
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $3,823 - $4,612	-52 Reduced 85.25%	9 $1,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $3,877 - $5,378	61 New	61 $5,000
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $3,073 - $3,736	-37 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $2,245 - $2,798	24 Added 184.62%	37 $4,000
Q2 2017 Aug 14, 2017	BUY	N/A	13	13 $2,000

Others Institutions Holding INCY

# of Institutions

694

Shares Held

194M

Call Options Held

564K

Put Options Held

331K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $14.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Incyte Corp Transaction History